Quoin Pharmaceuticals
PublicQuoin Pharmaceuticals is now publicly traded
The data on this page reflects Quoin Pharmaceuticals's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Series B
Sep 10, 2026
Total Funding Raised
$50M
Company Overview
Quoin Pharmaceuticals is a clinical-stage specialty pharmaceutical company that develops and commercializes therapeutic products for rare and orphan diseases.
Sector
Healthcare
AI Layer
Non-AI
Keywords
Quoin Pharmaceuticals Comparables
Compare Quoin Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dermelix Biotherapeutics | 83% | |
| Patagonia Pharmaceuticals, LLC | 78% | |
| Orvida Pharma Ltd. | 77% |
Quoin Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 10, 2026 |
Key People
Founding team and executive leadership
Quoin Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StemPoint Capital LP | Series B |
| Sphera Funds Management | Series B |
| Stonepine Capital Management | Series B |
Quoin Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access